Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Orexin receptor type 2 | ||
Ligand | BDBM386089 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Measurement of Orexin Type 2 Receptor Agonist Activity | ||
EC50 | 0.660±n/a nM | ||
Citation | Fujimoto, T; Rikimaru, K; Fukuda, K; Sugimoto, H; Matsumoto, T Substituted piperidine compound and use thereof US Patent US10508083 Publication Date 12/17/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Orexin receptor type 2 | |||
Name: | Orexin receptor type 2 | ||
Synonyms: | HCRTR2 | Hypocretin receptor type 2 | OX2R_HUMAN | Orexin receptor type 2 (OR 2) | Orexin receptor type 2 (OR-2) | Orexin receptor type 2 (OX2) | Orexin receptor type 2 (OX2R) | Orexin receptor type 2 (OxR2) | Ox-2-R | Ox2-R | ||
Type: | Protein | ||
Mol. Mass.: | 50710.53 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O43614 | ||
Residue: | 444 | ||
Sequence: |
| ||
BDBM386089 | |||
n/a | |||
Name | BDBM386089 | ||
Synonyms: | N-((2R,3S)-1-(cyclopropylcarbonyl)- 2-(((cis-4- phenylcyclohexyl)oxy)methyl)- piperidin-3-yl)methanesulfonamide | US10287305, Example 31 | US10508083, Example 31 | US11292766, Example 31 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H34N2O4S | ||
Mol. Mass. | 434.592 | ||
SMILES | CS(=O)(=O)N[C@H]1CCCN([C@H]1CO[C@H]1CC[C@H](CC1)c1ccccc1)C(=O)C1CC1 |r,wU:13.13,10.11,5.4,16.20,(6.67,.38,;5.33,1.15,;4.56,2.49,;6.1,2.49,;4,.38,;4,-1.15,;5.33,-1.93,;5.33,-3.47,;4,-4.23,;2.67,-3.47,;2.67,-1.93,;1.33,-1.15,;1.33,.38,;,1.15,;-1.33,.38,;-2.67,1.15,;-2.67,2.69,;-1.33,3.47,;,2.69,;-4,3.47,;-4,5,;-5.33,5.78,;-6.67,5,;-6.67,3.47,;-5.33,2.69,;1.33,-4.23,;1.33,-5.78,;,-3.47,;-.77,-2.13,;-1.54,-3.47,)| | ||
Structure |